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arrhythmias depends on the ability to evaluate the underlying
mechanism and to depict target sites for ablation [1–10].
Image fusion and integration have become routine proce-
dures in the diagnosis and treatment of various cardiovascu-
lar disorders [11–16]. Fusion of different imaging modalities
within one system may improve electroanatomical model-
ling and facilitate ablation procedures. Nowadays, three-
dimensional (3D) navigation systems are widely used for
pulmonary vein antrum isolation [17–24]. However, use of
electroanatomical mapping systems may increase proce-
dural duration and overheads, and may limit the choice of
ablation catheters. As an alternative to circumvent left atrial
mapping, 3D computed tomography (CT) reconstructions of
the left atrium can be superimposed directly (CT overlay) on
the fluoroscopy image to guide ablation catheters and to
mark ablation sites.
In the present issue of the Netherlands Heart Journal,
Van der Voort et al. [25] describe their initial experience
with 3D overlay for ablation of atrial fibrillation. They
evaluated the feasibility of the CT overlay technique for
pulmonary vein antrum isolation and its equivalence to
established electroanatomical mapping. To this purpose,
tion in 71 patients with atrial fibrillation. They performed
3D reconstructions of the left atrium, which were derived
from contrast cardiac CT and circumferential pulmonary
vein isolation. CT was initially performed using a 64-slice
CT scanner, and later a 256-slice CT scanner, with 85 ml of
intravenous contrast. Initial follow-up was scheduled at 2 to
3 months after each ablation, at 6 months, and for every
6 months subsequently. In subsequent ablation procedures,
veins were re-isolated, and defragmentation or linear lesions
were performed if necessary. Outcome was based on symp-
toms and subsequent electrocardiographic confirmation of
atrial fibrillation or tachycardia. The authors found that
adequate 3D reconstructions were formed and registered to
fluoroscopy in all patients. All veins, except 2 in one single
patient, could be isolated, resulting in freedom of atrial
fibrillation in 45 patients (63 %). In 19 patients a second
procedure was performed, in which 2.7±1.1 pulmonary
veins per patient were re-isolated; in 3 patients a third
procedure was performed. After follow-up of 15±8 months,
51 (91 %) patients with paroxysmal and 10 (67 %) with
persistent atrial fibrillation were free of arrhythmia.
The authors concluded that the results of 3D overlay for
circumferential pulmonary vein isolation are good. The 3D
overlay technique is comparable with other techniques, both
for paroxysmal and persistent atrial fibrillation. In addition, it
was demonstrated that the need for subsequent ablations
remains high due to a high incidence of recovery of conduction
from the pulmonary veins, but the recovery rate was similar to
standard techniques. Therefore, the outcomes of the 3D overlay
technique generally appear to be equivalent to other mapping
techniques. The authors further claim that, based on other
studies, their method of image integration is feasible in terms
of handling radiation exposure and having lower costs.
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The outcome of catheter ablation procedures for cardiac the authors performed circumferential pulmonary vein abla-
However, nowadays both patients and operators are entitled to
know the exact radiation dose they receive. Therefore, precise
data regarding the total radiation burden should be provided.
Along those lines, the potential cost reduction associated with
the 3D overlay technique should be given in more accurate
terms, certainly when the 3D technique is said to be equivalent
to other mapping techniques.
In a previous study by the same group [26], the authors
had already successfully evaluated 68 patients with sympto-
matic atrial fibrillation refractory to medical therapy who
were randomly assigned to CT overlay (group 1, n038) or to
a new image integration module called CartoMerge (group
2, n030). In that study they found that CT overlay for
pulmonary vein isolation is feasible and may, in comparison
with conventional left atrial navigation systems, shorten
procedural time without an increase in radiation burden.
In our centre, Tops et al. [27] had already shown in 16
patients with atrial fibrillation that CT images can be fused
with the three-dimensional electroanatomical mapping sys-
tem in an accurate manner. It was concluded that anatomy-
based catheter ablation procedures for atrial arrhythmias
may be facilitated by integration of different imaging
modalities. Also, Kardos et al. [28] showed that highly
accurate CT imaging and the electroanatomical map fusion
can be obtained by the Carto 3D electroanatomical mapping
system using the coronary sinus as the key anatomical
structure for registration. Using this technique the mapping
time of the left atrium can be reduced. Finlay et al. [29],
however, recently found in the CAVERN trial that Carto-
Merge appears to be faster and uses less fluoroscopy to
achieve registration than 3D image integration using NavX
Fusion, but overall procedural times and clinical outcomes
were similar.
To summarise, although the current study provides prom-
ising data, a prospective, randomised study should be con-
ducted–as the authors also indicated–to adequately compare
the current CT overlay technique with standard electroana-
tomical mapping systems in patients eligible for ablation of
atrial fibrillation.
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